Clinical development of bivalirudin (Angiox (R)): rationale for thrombin-specific anticoagulation in percutaneous coronary intervention and acute coronary syndromes

PWJC (Patrick) Serruys, Pascal Vranckx, K Allikmets

Research output: Contribution to journalArticleAcademicpeer-review

46 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)344-350
Number of pages7
JournalInternational Journal of Clinical Practice
Volume60
Issue number3
DOIs
Publication statusPublished - 2006

Cite this